These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 19650027)

  • 1. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
    Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL; Køber L; Torp-Pedersen C; Gislason GH
    Expert Opin Drug Saf; 2010 Nov; 9(6):893-903. PubMed ID: 20569079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study.
    Lanas A; Tornero J; Zamorano JL
    Ann Rheum Dis; 2010 Aug; 69(8):1453-8. PubMed ID: 20498210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the benefits and risks of drugs. The example of NSAIDs.
    Henry D
    Aust Fam Physician; 1990 Mar; 19(3):378-83, 385, 387. PubMed ID: 2185729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disadvantageous effects of nonsteroidal anti-inflammatory drugs on the alimentary tract.
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):403-8. PubMed ID: 12898870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practice implications of cardiovascular risks in NSAIDs.
    Hainsworth T
    Nurs Times; 2005 Jun 28-Jul 4; 101(26):26-7. PubMed ID: 16010838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescription of non-steroidal anti-inflammatory drugs].
    Bannwarth B
    Bull Acad Natl Med; 1998; 182(7):1431-7; discussion 1437-8. PubMed ID: 9916337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ; Benraad HB; Rasker JJ
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
    Weber AA; Hohlfeld T; Harder S
    Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in the elderly.
    Sahi SP; Basu SK; Bansal SK
    Br J Clin Pract; 1990 Jan; 44(1):22-3, 27. PubMed ID: 2317434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs).
    Valkhoff VE; van Soest EM; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1218-28. PubMed ID: 20222917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
    Knights KM; Mangoni AA; Miners JO
    Br J Clin Pharmacol; 2006 Jun; 61(6):738-40. PubMed ID: 16722838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.